| Mr Richard Sebastian Pagano, PT | |
|
1601 E Terra Ln, O Fallon, MO 63366-4414 | |
| (636) 978-6634 | |
| Not Available |
| Full Name | Mr Richard Sebastian Pagano |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 1601 E Terra Ln, O Fallon, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023328622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 113783 (Missouri) | Primary |
| Provider Name | Athletico Ltd |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1114449857 PECOS PAC ID: 4789602681 Enrollment ID: O20171211002357 |
News Archive
As the negotiations shift to the president and House speaker, some Republicans appear to be encouraging their colleagues to abandon staunch opposition to any tax rate hike, The Washington Post reports. But several outlets note that little movement is apparent from either side.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. hematologist-oncologists and managed care organization (MCO) pharmacy directors agree that survival effect is one of the attributes that most influences their decisions regarding prescribing and formulary status determinations, respectively, in patients with chronic myeloid leukemia who have failed first-line tyrosine kinase inhibitor therapy.
Two new studies led by researchers at McMaster University and St. Joseph's Healthcare Hamilton have found that individuals diagnosed with ADHD or obesity are more likely to choose smaller immediate rewards over larger future rewards.
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.
Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Richard Sebastian Pagano, PT 1601 E Terra Ln, O Fallon, MO 63366-4414 Ph: (636) 978-6634 | Mr Richard Sebastian Pagano, PT 1601 E Terra Ln, O Fallon, MO 63366-4414 Ph: (636) 978-6634 |
News Archive
As the negotiations shift to the president and House speaker, some Republicans appear to be encouraging their colleagues to abandon staunch opposition to any tax rate hike, The Washington Post reports. But several outlets note that little movement is apparent from either side.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. hematologist-oncologists and managed care organization (MCO) pharmacy directors agree that survival effect is one of the attributes that most influences their decisions regarding prescribing and formulary status determinations, respectively, in patients with chronic myeloid leukemia who have failed first-line tyrosine kinase inhibitor therapy.
Two new studies led by researchers at McMaster University and St. Joseph's Healthcare Hamilton have found that individuals diagnosed with ADHD or obesity are more likely to choose smaller immediate rewards over larger future rewards.
Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces that it has filed an investigational new drug application with the US Food and Drug Administration to initiate a Phase 3 pivotal study of ST10, its novel oral iron-replacement therapy, for the treatment of iron deficiency anaemia in pre-dialysis patients with chronic kidney disease.
Avita Medical Ltd., the regenerative medicine company, today announced that the United States Food and Drug Administration (FDA) has approved the Company's investigational device exemption (IDE) feasibility study for the use of ReCell Spray-On-Skin in the treatment of hypertrophic dyspigmented scars: i.e., raised and/or discoloured scars.
› Verified 8 days ago
Athletico Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 343 Winding Woods Ctr, O Fallon, MO 63366 Phone: 636-439-2004 Fax: 636-439-2054 | |
Jennifer Jo Freeling, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3404 E Terra Ln, O Fallon, MO 63366 Phone: 636-970-0336 Fax: 636-970-0337 | |
Ms. Kathryn R Summers, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 939 Highway K, O Fallon, MO 63366 Phone: 636-240-7000 Fax: 636-240-7513 | |
Lorenzo G Catapang, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 343 Winding Woods Ctr, O Fallon, MO 63366 Phone: 636-439-2004 Fax: 636-439-2054 | |
Caitlin M Niemeier, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1096 Tom Ginnever Ave, O Fallon, MO 63366 Phone: 636-978-5255 Fax: 636-978-5287 | |
Stephanie Ward, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 951 Waterbury Falls Dr, O Fallon, MO 63368 Phone: 636-336-0300 Fax: 636-336-0297 |